FdaApplication
BLA 761224
Identifiers
- fda_app_no: BLA761224
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca AB |
| application_type | BLA |
| approval_date | 2021-12-17 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TEZSPIRE | TEZEPELUMAB-EKKO | 210MG/1.91ML (110MG/ML) | Injection |
| TEZSPIRE | — | 210MG/1.91ML (110MG/ML) | Injection |
| TEZSPIRE | — | 210MG/1.91ML (110MG/ML) | Injection |
3 products